Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pischon, Tobias Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (16) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (145) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Pezzutto, Antonio Prof. Dr. (4) (-) Popp, Oliver Dr. (3) Advanced Light Microscopy (1) Ankerproteine und Signaltransduktion (2) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (2) Electron Microscopy (1) Entwicklung Mechanismus-basierter Krebstherapien (9) Entwicklungsneurobiologie (1) Experimentelle Ultrahochfeld-MR (2) Flow Cytometry (1) Genetik und Genomik von Herz- Kreislauferkrankungen (5) Genom-Editierung & Krankheitsmodelle (2) Genomdiversifikation & Integrität (1) Hochschulambulanz für Neuroimmunologie (1) Immundysregulationen in der Onkologie (2) Immunregulation und Krebs (2) Integrative Vaskuläre Biologie (4) Intrazelluläre Proteolyse (6) Magnetic Resonance (2) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Herz- Kreislaufforschung (3) Molekulare Immunologie und Gentherapie (21) Molekulare Onkologie (1) Myologie (1) Protein Production and Characterization (1) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Proteomics (31) Psychoneuroimmunologie (5) Strukturbiologie Membran-assoziierter Prozesse (1) Synaptische Transmission und Plastitzität (1) Transgenics (2) Translational Bioinformatics (4) (-) Translationale Onkologie solider Tumore (7) Zelluläre Neurowissenschaften (7) 2005 (1) 2012 (2) 2021 (2) 2022 (2) 7 Ergebnisse: Active Filter: Pezzutto, Antonio Prof. Dr.Popp, Oliver Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto 01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann 30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto 23. Juni 2022 / Methods Mol Biol Gene gun Her2/neu DNA vaccination: evaluation of vaccine efficacy in a syngeneic Her2/neu mouse tumor model T. Nguyen-Hoai O. Hohn A. Pezzutto J. Westermann 23. Februar 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke 26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein 21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein
01. Januar 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto
01. Dezember 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann
30. April 2012 / Immunol Lett Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms O. Schmetzer G. Moldenhauer A. Nicolaou P. Schlag R. Riesenberg A. Pezzutto
23. Juni 2022 / Methods Mol Biol Gene gun Her2/neu DNA vaccination: evaluation of vaccine efficacy in a syngeneic Her2/neu mouse tumor model T. Nguyen-Hoai O. Hohn A. Pezzutto J. Westermann
23. Februar 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke
26. August 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
21. Oktober 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein